Biotecnología
Biotecnología
MilliporeSigma Agrees to Acquire Mirus Bio for $600M
27/05/2024 -
Mirus Bio develops & commercializes transfection reagents, which play a critical role in the production of viral vector-based gene therapies.
Nanoscope Therapeutics Names New SVP of Regulatory and Quality
16/05/2024 -
Dr. Khandan Baradaran boasts nearly two decades of experience in manufacturing and regulatory review of gene therapy products.
bluebird bio Completes First Commercial Cell Collection for LYFGENIA
07/05/2024 -
One-time gene therapy for the treatment of sickle cell disease was approved by the FDA in December 2023.
ProPharma & PBL Introduce Cell Factory Box
06/05/2024 -
Enables decentralized manufacturing of all types of Cell & Gene Therapies.
Charles River Launches AAV and LVV Reference Materials Portfolio
06/05/2024 -
Is designed to streamline Cell and Gene Therapy research and development as it scales to Good Manufacturing Practice quality.
Abzena Introduces Enhanced Bioassay Platform
02/05/2024 -
EpiScreen 2.0 predicts and evaluates potential risks of preclinical immunogenicity in protein, antibody and gene therapy therapeutics.
Lexeo Enters License Agreement for Friedreich Ataxia Treatment
25/04/2024 -
Aims to expedite development of investigational gene therapy candidate LX2006 for the treatment of FA cardiomyopathy.
Ferring and SK Pharmteco Partner to Increase Production of ADSTILADRIN
19/04/2024 -
Will scale up commercial manufacturing capacity for the drug substance of Ferring’s intravesical non-replicating gene therapy.
Session at AAPS National Biotechnology Conference to Cover Gene & Therapy Market
16/04/2024 -
‘Cell and Gene Therapies at the Intersection of Business and Science,’ will take place on May 14 at 9:30 a.m. in San Francisco.
CSafe Launches Three New Cold Chain Technologies
16/04/2024 -
Multi-Use Dewars designed to serve cell and gene therapy market, CSafe Connect Control Tower monitoring service, and Silverpod MAX RE.
Charles River & Axovia Partner to Support Development of Gene Therapies for Ciliopathies
10/04/2024 -
Axovia will leverage Charles River’s plasmid platform and expertise in plasmid DNA production to accelerate time to clinic.
Ascend Acquires Florida Facility and Expertise, Bolstering Gene Therapy Development
10/04/2024 -
Enters long-term partnership with Beacon to continue manufacturing its products for clinical and commercial use.
Andelyn Biosciences Partners with Grace Science to Advance GS-100
26/03/2024 -
Will tech transfer Phase I/II/III manufacturing of the suspension process adeno-associated virus (aav) gene therapy for NGLY1 deficiency.
Forge’s AAV Gene Therapy Granted Innovation Passport Designation in Krabbe Disease
24/03/2024 -
FBX-101 was created for the treatment of patients with Krabbe disease, a rare neurodegenerative disease.
Charles River Extends Gene Therapy Alliance with NUS Medicine
24/03/2024 -
Will support NUS Medicine in the development of engineered stem cells for cancer therapy.
Charles River, Navega Therapeutics Enter Gene Therapy Mfg. Pact
15/03/2024 -
Will leverage Charles River’s off-the-shelf plasmid products, custom plasmid capabilities, and GMP-grade AAV production.
Seattle Children's Research Institute & Genezen Partner to Advance XLA Gene Therapy
11/03/2024 -
Will leverage Genezen’s viral vector process development and cGMP manufacturing expertise to advance Seattle Children’s XLA gene therapy program.
Ginkgo Bioworks Acquires Patch Biosciences
29/02/2024 -
Strengthens its Gene Therapy Services, Cell Therapy Services, and RNA Therapeutics Services.
Azzur Group Introduces Analytical Laboratory Testing Services
22/02/2024 -
Aims to enable industry pioneers in the delivery of novel cell and gene therapies.
SCHOTT Pharma Introduces EVERIC Freeze Vials for Deep-Cold Storage
08/02/2024 -
Optimized for vaccines, such as gene therapy and mRNA medications at temperatures down to -80°C.
Human Gene Therapy Products Incorporating Human Genome Editing
06/02/2024 -
This is the guidance Human Gene Therapy Products Incorporating Human Genome Editing
